KR100500373B1 - Composition for hangover cures - Google Patents
Composition for hangover cures Download PDFInfo
- Publication number
- KR100500373B1 KR100500373B1 KR10-2002-0083331A KR20020083331A KR100500373B1 KR 100500373 B1 KR100500373 B1 KR 100500373B1 KR 20020083331 A KR20020083331 A KR 20020083331A KR 100500373 B1 KR100500373 B1 KR 100500373B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- hangover
- present
- drinking
- dermis
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 206010019133 Hangover Diseases 0.000 title claims abstract description 24
- 210000004207 dermis Anatomy 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 8
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 8
- 229940010454 licorice Drugs 0.000 claims description 8
- 241000287828 Gallus gallus Species 0.000 claims description 7
- 241000411851 herbal medicine Species 0.000 claims description 7
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims 1
- 238000002481 ethanol extraction Methods 0.000 claims 1
- 238000003808 methanol extraction Methods 0.000 claims 1
- 230000035622 drinking Effects 0.000 abstract description 14
- 239000000284 extract Substances 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 8
- 235000013376 functional food Nutrition 0.000 abstract description 5
- 230000002443 hepatoprotective effect Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 14
- 235000019441 ethanol Nutrition 0.000 description 14
- 239000007788 liquid Substances 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- 241000202807 Glycyrrhiza Species 0.000 description 7
- 241000234314 Zingiber Species 0.000 description 6
- 235000006886 Zingiber officinale Nutrition 0.000 description 6
- 235000008397 ginger Nutrition 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 235000008434 ginseng Nutrition 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 description 3
- 240000000171 Crataegus monogyna Species 0.000 description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 3
- 241000276438 Gadus morhua Species 0.000 description 3
- 208000024330 bloating Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000019997 soju Nutrition 0.000 description 3
- 206010048909 Boredom Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000003077 lignite Substances 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- -1 drinks Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940034290 nausea control Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
Abstract
본 발명은 숙취해소용 조성물 및 이를 함유하는 건강기능식품에 관한 것으로, 보다 상세하게는 진피, 백복령, 인진, 갈화 및 갈근의 추출물을 포함하는 숙취해소용 조성물에 관한 것으로, 음주로 인한 숙취증상 전반에 대해 우수한 해소 작용을 가지며, 더불어 인체에 부작용이 없고, 간장보호 효과가 우수하여 음주 전 또는 음주 후에 숙취해소를 위해 사용될 수 있다. The present invention relates to a hangover relief composition and a health functional food containing the same, and more particularly, to a hangover relief composition comprising extracts of dermis, baekbokyeong, injin, browning and brown root, overall hangover symptoms due to drinking It has an excellent resolving action against, and has no side effects on the human body, and has an excellent hepatoprotective effect so that it can be used for hangover relief before or after drinking.
Description
본 발명은 숙취해소용 조성물 및 이를 함유하는 건강기능식품에 관한 것으로, 보다 상세하게는 진피, 백복령, 인진, 갈화 및 갈근의 추출물을 포함하는 숙취해소용 조성물에 관한 것이다. The present invention relates to a hangover relieving composition and a health functional food containing the same, and more particularly to a hangover relieving composition comprising the extract of the dermis, baekbokyeong, injin, browning and root.
숙취현상은 간세포에 축적된 에탄올 또는 아세트알데히드의 독작용에 의해 발생하는 것으로, 이들 물질이 간세포에 장기간 축적되어 독작용이 지속되면, 피로감, 전신권태, 복부팽만감, 구토 등의 증상을 일으키게 된다. The hangover is caused by the poisoning effect of ethanol or acetaldehyde accumulated in hepatocytes, and if these substances accumulate in the liver cells for a long time and cause poisoning, symptoms such as fatigue, general boredom, bloating, and vomiting are caused.
정상적인 에틸알콜의 대사과정은 에틸알콜이 체내에 유입되면 위장 또는 소장에서 흡수되어 혈관중에 들어가 간장으로 옮겨지게 된다. 간세포에는 알콜탈수소효소가 있어, 알콜을 아세트알데히드로 산화시키고, 상기 아세트알데히드는 간세포에 있는 아세트알데히드 탈수소효소에 의해 초산으로 분해되어 전신의 근육이나 지방조직으로 옮겨져 최종적으로는 탄산가스와 물로 분해되는 것이다. Normal metabolism of ethyl alcohol when it enters the body is absorbed by the stomach or small intestine and enters the blood vessels and is transferred to the liver. Hepatocytes contain alcohol dehydrogenases, which oxidize alcohols to acetaldehyde, which are decomposed into acetic acid by acetaldehyde dehydrogenases in hepatocytes, which are transferred to muscle and adipose tissue throughout the body and finally to carbon dioxide and water. will be.
또한 상기 아세트알데히드 효소에는 아세트알데히드가 저농도이더라도 산화를 개시하는 II형과 아세트알데히드가 고농도로 되지 않으면 작용하지 않는 I형이 있으나, 동양인은 일반적으로 II형 아세트알데히드 효소가 결핍 또는 부족하기 때문에 아세트알데히드의 산화가 느리고, 따라서 산화되지 아니한 아세트알데히드 또는 에틸알콜의 독작용에 의해 정상적인 신진대사가 방해받아 다양한 숙취현상을 느끼게 되는 것이다. In addition, the acetaldehyde enzyme has type II which initiates oxidation even at low concentrations of acetaldehyde and type I which does not work unless acetaldehyde does not have high concentration, but oriental people generally lack or lack acetaldehyde enzyme because acetaldehyde is deficient. Oxidation is slow, and thus normal metabolism is disturbed by the poisoning of acetaldehyde or ethyl alcohol, which is not oxidized, resulting in various hangover phenomena.
이러한 음주후의 숙취현상을 해소하기 위하여 생약제제 또는 인공제제를 단독으로 또는 혼합하여 제조한 드링크류가 다수 개발되었다. 한약제 또는 민간요법제로서 숙취해소에 유용한 효과가 있다고 알려져 있는 인삼, 가시오가피 등의 성분을 주성분으로 하는 각종 제제 형태의 의약품 및 인삼 등을 주성분으로 하는 자양강장 드링크제가 개발되어 있는 실정이다. 그러나 이들 제제나 드링크제는 음주에 의해 유발되는 다양한 변화들중 일부의 항목에만 효과가 있으며, 약효 또한 미비한 것으로 나타나 있다. 또한 이를 개선한 생약추출물의 발명의 경우 거의 종래의 한방제제로 이용되어 온 생약 추출물을 단순히 혼합하여 사용하고 있어, 숙취해소에 가장 적합한 처방을 하지 못하고 있다. In order to alleviate the hangover after drinking alcohol, a large number of drinks prepared by mixing or combining herbal preparations or artificial preparations have been developed. As a herbal or folk remedy, nourishment tonic drinks have been developed that are mainly composed of ginseng and ginseng, which are known to be effective in relieving hangover. However, these preparations and drink products are effective only in the items of some of the various changes caused by drinking, the drug is also shown to be inadequate. In addition, in the case of the invention of the herbal extracts improved to improve the use of herbal extracts that have been used almost as a conventional herbal preparations, it is not the best prescription for hangover relief.
이에 본 발명자들은 예의 연구를 거듭한 결과, 음주로 인한 숙취증상 전반에 대해 우수한 해소 작용을 가지는 신규한 숙취해소용 조성물을 개발하여 본 발명을 완성하였다. Accordingly, the present inventors have intensively studied, and completed the present invention by developing a novel hangover relief composition having an excellent resolution for the overall hangover symptoms caused by drinking.
본 발명의 목적은 음주로 인한 숙취증상 전반에 대해 우수한 해소 작용을 가지며, 더불어 인체에 부작용이 없고, 간장보호 효과가 우수한 음주 전 또는 음주 후에 사용될 수 있는 숙취해소용 조성물을 제공하는 것이다. An object of the present invention is to provide a hangover relief composition that has an excellent resolution for the hangover symptoms caused by drinking, and also has no side effects on the human body, and can be used before or after drinking with excellent hepatoprotective effects.
본 발명의 다른 목적은 상기 조성물을 포함하는 건강기능식품을 제공하는 것이다.Another object of the present invention to provide a health functional food comprising the composition.
상기 목적을 달성하기 위해, 본 발명은 진피, 백복령, 인진, 갈화 및 갈근의 수 추출물 또는 알콜 추출물을 포함하는 숙취해소용 조성물을 제공한다. In order to achieve the above object, the present invention provides a hangover relief composition comprising a water extract or alcohol extract of dermis, baekbokyeong, jinjin, browning and brown root.
본 발명의 조성물에 있어서, 상기 추출물은 원료 생약인 진피, 백복령, 인진, 갈화 및 갈근을 중량비 1∼5 : 1∼5 : 3∼25 : 1∼5 : 1∼5로 혼합하여 추출하거나, 각각의 생약을 추출하여 상기 중량비로 혼합한 것이 바람직하다. In the composition of the present invention, the extract is extracted by mixing the raw material herbal dermis, baekbokyeong, phosphorus, browning and brown root in a weight ratio of 1 to 5: 1 to 5: 3 to 25: 1 to 5: 1 to 5, or It is preferable to extract the herbal medicines and mix them in the above weight ratio.
또한 본 발명의 조성물은 창출, 감초, 육계, 생강, 사인, 산약, 산사 및 맥아의 수 추출물 및 알콜 추출물로 이루어진 군에서 선택되는 하나 이상의 추출물을 더 포함할 수 있다. In addition, the composition of the present invention may further comprise one or more extracts selected from the group consisting of extract, licorice, broiler, ginger, cod, powder, mountain sand and malt and alcohol extract.
본 발명의 바람직한 일 구체예에 있어서, 진피, 백복령, 인진, 갈화, 갈근, 창출, 감초, 육계, 생강, 사인, 산약, 산사 및 맥아를 중량비 1∼5 : 1∼5 : 3∼25 : 1∼5 : 1∼5 : 0.5∼3 : 0.5∼3 : 0.5∼3 : 1∼10 : 0.3∼3 : 0.3∼3 : 0.3∼3 : 0.3∼3로 혼합하여 추출하거나, 각각의 생약을 추출하여 상기 중량비로 혼합한 것이 바람직하다. In one preferred embodiment of the present invention, the dermis, baekbokyeong, injin, browning, brown root, creation, licorice, broiler, ginger, cod, powder, 1 ~ 5: 1 ~ 5: 3 ~ 25: 1 -5: 1-5: 0.5-3: 0.5-3: 0.5-3: 1-10: 0.3-3: 0.3-3: 0.3-3: 0.3-3, or each herbal extract is extracted, It is preferable to mix in the said weight ratio.
이하, 본 발명을 상세하게 설명한다. EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail.
본 발명의 조성물에 있어서, 각각 생약들을 통상의 방법에 의해 각각 추출하고 그 추출물들을 혼합하거나, 생약들을 혼합한 후 한꺼번에 추출할 수 있고, 필요한 경우 이를 농축 건조하여 분말화 할 수도 있다. In the composition of the present invention, each of the herbal medicines can be extracted by a conventional method and mixed with the extract, or after mixing the herbal medicines can be extracted all at once, and if necessary it can be concentrated to dry powdered.
본 발명에 있어서, 바람직하게는 각 생약들을 규정된 중량비로 혼합한 후, 물 또는 알콜을 용매로 사용하여 열탕추출, 소니케이션 등 통상의 방법으로 추출한다. 알콜을 사용할 경우 메탄올 또는 에탄올을 사용하는 것이 바람직하다. In the present invention, preferably, each herbal medicine is mixed in a prescribed weight ratio, and then extracted with conventional methods such as hot water extraction and sonication using water or alcohol as a solvent. If alcohol is used, it is preferred to use methanol or ethanol.
본 발명에 따른 조성물의 제조 원료는 바람직하게는 진피, 백복령, 인진, 갈화 및 갈근이 1∼5 : 1∼5 : 3∼25 : 1∼5 : 1∼5의 중량비로 혼합된 것이며, 특히 바람직하게는 상기 조성물에 창출, 감초, 육계, 생강, 사인, 산약, 산사 또는 맥아의 하나 이상의 생약을, 진피의 중량에 대하여 0.5∼3 : 0.5∼3 : 0.5∼3 : 1∼10 : 0.3∼3 : 0.3∼3 : 0.3∼3 : 0.3∼3의 중량비로 추가적으로 혼합할 수 있다. The raw material for the preparation of the composition according to the present invention is preferably a mixture of dermis, baekbokyeong, phosphorus, browning and brown root in a weight ratio of 1 to 5: 1 to 5: 3 to 25: 1 to 5: 1 to 5, and particularly preferred. Preferably, the composition contains at least one herbal medicine of licorice, licorice, broiler, ginger, cod, powder, hawthorn or malt, based on the weight of the dermis 0.5 to 3: 0.5 to 3: 0.5 to 3: 1 to 10: 0.3 to 3 The mixture may be further mixed in a weight ratio of 0.3 to 3: 0.3 to 3: 0.3 to 3.
상기 생약들의 조성비는 반복된 실험결과를 토대로 얻어진 것이며 그 하한치보다 낮을 경우에는 그 성분의 생리활성 효과가 감소하며, 그 상한치 보다 높을 경우에는 타 성분의 생리활성 효과가 감소될 수 있어 조성물의 상승작용 및 협동작용이 저하될 우려가 있다. The composition ratio of the herbal medicines is obtained on the basis of repeated experimental results, and when lower than the lower limit, the physiological activity effect of the component is reduced, and when higher than the upper limit, the physiological activity effect of the other components may be reduced, thereby synergistically And there is a fear that the cooperation is lowered.
본 발명의 조성물은 예를 들어 진피, 백복령, 인진, 갈화, 갈근, 창출, 감초, 육계, 생강, 사인, 산약, 산사 및 맥아를 200g : 100g : 600g : 200g : 200g : 100g : 100g : 50g : 300g : 100g : 100g : 100g : 100g으로 혼합하여 얻은 혼합물에 물 1리터를 붓고 약 2시간 동안 달인 후 약 300ml로 농축시켜 탕제로 제조할 수 있다. The composition of the present invention is 200g: 100g: 600g: 200g: 200g: 100g: 100g: 50g: dermis, baekbokyeong, jinjin, browning, brown root, creation, licorice, broiler, ginger, coriander, powder, hawthorn and malt 1 g of water is poured into the mixture obtained by mixing 300 g: 100 g: 100 g: 100 g: 100 g, decocted for about 2 hours, and concentrated to about 300 ml.
본 발명의 조성물은 약제학적 분야에서 공지의 방법의 의해 제제화할 수 있고, 추출물 자체 또는 약제학적으로 허용되는 담체, 부형제 등과 혼합하여 통상의 약학적 제제, 예를 들면 드링크제와 같은 액제, 시럽제, 캡슐제 등으로 제제화될 수 있으며, 이들은 경구 또는 비경구로 투여될 수 있다. 본 발명의 조성물은 빠른 효과를 위해서 드링크제로써 음주 전 및/또는 후에 경구 투여하는 것이 바람직하다. The compositions of the present invention may be formulated by methods known in the pharmaceutical art and may be mixed with the extract itself or with a pharmaceutically acceptable carrier, excipient, etc., to form a conventional pharmaceutical preparation, for example liquids such as drinks, syrups, capsules. Formulations and the like, which can be administered orally or parenterally. The composition of the present invention is preferably administered orally before and / or after drinking as a drink for quick effect.
상기 본 발명의 조성물을 포함하는 액제, 캡슐제 등은 건강기능식품으로 사용하는 것이 바람직하며, 본 발명에서 사용된, 용어 "건강기능식품"이라 함은 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 정제, 캅셀, 분말, 과립, 액상, 환 등의 형태로 제조 가공한 식품을 말한다.The liquid, capsules and the like containing the composition of the present invention is preferably used as a health functional food, the term "health functional food" used in the present invention is used as a raw material or ingredient having a useful functionality to the human body Refers to food products manufactured and processed in the form of tablets, capsules, powders, granules, liquids, and pills.
본 발명의 조성물은 체내에서 활성성분의 흡수도, 배설속도, 환자의 연령 및 체중, 성별 및 상태, 치료할 질병의 중증정도 등에 따라 적절히 선택되나, 통상적인 1회 투여량은 상기 탕제 기준 체중 1kg 당 1.0∼5ml이며, 이를 1일 1∼3회 복용한다. 기타 제제에 있어서도 상기 액제 복용량을 고려하여 산출된 적정량을 경구 투여할 수 있다. The composition of the present invention is appropriately selected depending on the absorption of the active ingredient in the body, the rate of excretion, the age and weight of the patient, the sex and condition, the severity of the disease to be treated, etc. 1.0 to 5 ml, which is taken 1 to 3 times a day. In other formulations, an appropriate amount calculated in consideration of the liquid dosage can be administered orally.
이하, 본 발명을 하기 실시예에 의하여 보다 구체적으로 설명하지만, 이들에 의해 본 발명의 범위가 어떤 식으로든 제한되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to the following examples, but the scope of the present invention is not limited by them in any way.
실시예 1: 액제의 제조Example 1 Preparation of Liquid
진피 200g, 백복령 150g, 인진 600g, 갈화 150g 및 갈근 150g을 혼합한 후, 여기에 물 800ml를 붓고, 약 2시간 동안 달인 후 약 200ml로 농축시켜 액제를 제조하였다. 200 g of dermis, 150 g of Baekbokryeong, 600 g of phosphorus, 150 g of browning and 150 g of brown root were mixed and then poured into 800 ml of water, decocted for about 2 hours, and concentrated to about 200 ml to prepare a liquid formulation.
실시예 2: 액제의 제조Example 2: Preparation of Liquid
진피 200g, 백복령 200g, 인진 600g, 갈화 150g, 갈근 200g 및 창출 150g을 혼합한 후, 여기에 에탄올 600ml를 붓고 소니케이션하여 추출하고, 감압하에 농축하였다(수율 5.8%). 상기 농축물에 증류수 200ml를 가하고, 여과하여 액제를 제조하였다. After mixing 200 g of dermis, 200 g of Baekbokryeong, 600 g of phosphorus, 150 g of browning, 200 g of brown root and 150 g of production, 600 ml of ethanol was poured into it, extracted by sonication, and concentrated under reduced pressure (yield 5.8%). 200 ml of distilled water was added to the concentrate, followed by filtration to prepare a liquid.
실시예 3: 액제의 제조Example 3: Preparation of Liquid
진피 200g, 백복령 100g, 인진 1000g, 갈화 200g, 갈근 200g, 창출 100g, 육계 50g, 산약 100g을 혼합한 후, 여기에 물 900ml를 붓고, 약 2시간 동안 달인 후 약 250ml로 농축시켜 액제를 제조하였다. 200g of dermis, 100g of Baekbokryeong, 1000g of phosphorus, 200g of gallium, 200g of brown root, 100g of ginseng, 50g of broiler, 100g of medicinal herb, and then poured 900ml of water, decoction for about 2 hours and concentrated to about 250ml to prepare a liquid formulation. .
실시예 4: 액제의 제조Example 4: Preparation of Liquid
진피 150g, 백복령 150g, 인진 800g, 갈화 200g, 갈근 200g, 창출 80g, 감초 100g, 사인 50g, 산약 50g 및 생강 150g을 혼합한 후, 여기에 물 900ml를 붓고, 약 2시간 동안 달인 후 약 250ml로 농축시켜 액제를 제조하였다. 150g of dermis, 150g of Baekbokyeong, 800g of ginseng, 200g of lignite, 200g of brown root, creation 80g, 100g of licorice, 50g of cod, 50g of acid and 50g of ginger, and then poured 900ml of water, decoction for about 2 hours, and then about 250ml Concentration prepared a liquid.
실시예 5: 액제의 제조Example 5: Preparation of Liquid
진피 200g, 백복령 100g, 인진 600g, 갈화 200g, 갈근 200g, 창출 100g, 감초 100g, 육계 50g, 생강 300g, 산약 100g, 사인 100g, 산사 100g 및 맥아 100g을 혼합한 후, 여기에 물 1리터를 붓고, 약 2시간 동안 달인 후 약 300ml로 농축시켜 액제를 제조하였다. 200 g of dermis, 100 g of Baekbokryeong, 600 g of ginseng, 200 g of lignite, 200 g of brown root, creation 100 g, licorice 100 g, broiler 50 g, 300 g of ginger, 100 g of cabbage, 100 g of cod, 100 g of hawthorn and 100 g of malt, and then pour 1 liter of water , Decoction for about 2 hours and concentrated to about 300ml to prepare a liquid.
실시예 6: 기타 제제의 제조Example 6: Preparation of Other Formulations
통상의 방법에 따라 실시예 1 내지 5의 추출물 각각으로 환제, 과립제, 정제 또는 캅셀제를 제조하였다. Pills, granules, tablets or capsules were prepared from each of the extracts of Examples 1 to 5 according to conventional methods.
실험예 1. 혈중농도 측정 Experimental Example 1. Measurement of blood concentration
상기 실시예 1 및 실시예 5의 조성물에 대한 숙취해소 효과를 측정하기 위해, 30대의 건강한 성인 50명(남성 37명, 여성 13명)을 대상으로 혈중 알콜농도측정 실험을 하였다. 50명을 대조군(10명), 전투여군(20명), 후투여군(20명)으로 나누고, 각각 360ml의 소주 한병을 음주하게 한 후, 통상의 방법으로 혈중 알콜농도를 측정하였다. 전투여군은 소주 음주 1시간전에 실시예 1 또는 실시예 5의 조성물 각각 100ml를 복용한 군이며, 후투여군은 소주 섭취후 바로 실시예 1 또는 실시예 5의 조성물 각각 100ml를 복용한 군이다. 결과를 하기 표 1에 나타내었다(값은 평균±표준편차를 나타냄). In order to measure the hangover effect on the compositions of Examples 1 and 5, blood alcohol concentration test was performed on 50 healthy adults (37 males, 13 females) in their 30s. Fifty patients were divided into a control group (10), a combat female group (20 persons), and a post-administration group (20 persons). Each of them was allowed to drink a bottle of 360 ml of soju, and blood alcohol levels were measured by a conventional method. Combat female is a group taking 100ml each of the composition of Example 1 or Example 1 hour before drinking soju, the post-administration group is a group taking 100ml each of the composition of Example 1 or Example 5 immediately after ingesting soju. The results are shown in Table 1 below (values represent mean ± standard deviation).
표 1 (단위 : %) Table 1 (Unit:%)
상기 표 1과 같이, 본 발명의 실시예 1 및 5의 조성물을 음주 전·후에 복용시에 본 발명의 조성물을 투여하지 않은 대조군에 비해 혈중 알콜 농도가 현저히 감소하였다. As shown in Table 1, the concentration of alcohol in the blood was significantly reduced compared to the control group not administered the composition of the compositions of Examples 1 and 5 of the present invention before and after drinking.
실험예 2. 숙취해소의 측정Experimental Example 2. Measurement of hangover relief
상기 실험예 1의 성인 50명을 대상으로 실험예 1과 같이 실시예 1 또는 5의 조성물을 투여하고, 음주후 7시간 후의 숙취의 해소에 대한 검사를 실시하였고, 그 결과를 하기에 표 2에 나타내었다(값은 평균±표준편차를 나타냄). The composition of Example 1 or 5 was administered to 50 adults of Experimental Example 1 as in Experimental Example 1, and a test for elimination of hangover after 7 hours after drinking was performed. The results are shown in Table 2 below. (Values represent mean ± standard deviation).
표 2TABLE 2
(주) 증상의 정도는 하기와 같다.(Note) The degree of symptoms is as follows.
5: 매우 심함; 4: 심함; 3: 보통; 2: 완화; 1 : 미약; 0: 없음5: very severe; 4: severe; 3: normal; 2: mitigation; 1: weak; 0: none
상기 표 2와 같이, 본 발명의 실시예 1 및 5의 조성물을 음주 전·후에 복용할 때, 숙취의 제증상인 피로감, 전신권태, 복부팽만감, 구토 등의 모든 증상이 개선되었다. As shown in Table 2, when taking the compositions of Examples 1 and 5 of the present invention before and after drinking, all symptoms such as fatigue, general boredom, bloating, vomiting, etc. are symptoms of hangover.
이상에서 알 수 있는 바와 같이, 본 발명의 조성물은 음주로 인한 숙취증상 전반에 대해 우수한 해소 작용을 가지며, 더불어 인체에 부작용이 없고, 간장보호 효과가 우수하여 음주 전 또는 음주 후에 숙취해소를 위해 사용될 수 있다. As can be seen from the above, the composition of the present invention has an excellent resolution for the overall hangover symptoms due to drinking, and also has no side effects on the human body, and has an excellent hepatoprotective effect to be used for hangovers before or after drinking. Can be.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0083331A KR100500373B1 (en) | 2002-12-24 | 2002-12-24 | Composition for hangover cures |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0083331A KR100500373B1 (en) | 2002-12-24 | 2002-12-24 | Composition for hangover cures |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040056769A KR20040056769A (en) | 2004-07-01 |
KR100500373B1 true KR100500373B1 (en) | 2005-07-11 |
Family
ID=37349413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0083331A KR100500373B1 (en) | 2002-12-24 | 2002-12-24 | Composition for hangover cures |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100500373B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101394358B1 (en) | 2013-10-08 | 2014-05-13 | 주식회사 엘지생활건강 | Health composition relieving alcohol hangover |
KR20230050601A (en) | 2021-10-08 | 2023-04-17 | 자람푸드 농업회사법인 주식회사 | Method of manufacturing hangover relieving drink using seaweed. |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100811683B1 (en) * | 2006-11-21 | 2008-03-11 | 영남대학교 산학협력단 | Composition for improving gastrointestinal function comprising an extract of dioscoreaceae as active ingredient and functional health food comprising the same |
KR101539864B1 (en) * | 2013-01-30 | 2015-07-28 | 이항종 | Beverage for curing of hangover |
KR101894653B1 (en) * | 2016-01-14 | 2018-10-04 | 주식회사 프라임오라 | Composition for eliminating hangover |
KR101953441B1 (en) * | 2016-11-07 | 2019-02-28 | 김대호 | Composition for hangover annul material based on oriental medicine material, manufacturing method for pill type hangover annul material using the same, and pill type hangover annul material manufactured by the same |
KR101859722B1 (en) * | 2018-01-19 | 2018-05-18 | 주식회사 엘지생활건강 | Pear puree containing composition for relieving alcohol hangover |
KR101982816B1 (en) | 2018-08-23 | 2019-05-29 | 주식회사 비앤에이치랩 | Composition for removing hangover and improving liver function containing Saltwort |
-
2002
- 2002-12-24 KR KR10-2002-0083331A patent/KR100500373B1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101394358B1 (en) | 2013-10-08 | 2014-05-13 | 주식회사 엘지생활건강 | Health composition relieving alcohol hangover |
KR20230050601A (en) | 2021-10-08 | 2023-04-17 | 자람푸드 농업회사법인 주식회사 | Method of manufacturing hangover relieving drink using seaweed. |
Also Published As
Publication number | Publication date |
---|---|
KR20040056769A (en) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5284097B2 (en) | Anti-obesity composition | |
JP2009511468A5 (en) | ||
US5324516A (en) | Galenic composition for decreasing blood alcohol concentration | |
CN102836379B (en) | Traditional Chinese medicine compound preparation for reducing lipid and dispelling effects of alcohol as well as preparation method and application of same | |
CA2627314C (en) | Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves | |
CN104740412B (en) | A kind of Medicament for Alcoholism composition and preparation method thereof | |
JPH08127538A (en) | Antidiabetic agent | |
KR20110033644A (en) | Composition for curing hangover and method manufacturing thereof | |
US5482712A (en) | Galenic composition | |
KR20040030370A (en) | A functional food Containing herbes composition for allergy disease treatment | |
KR100500373B1 (en) | Composition for hangover cures | |
CN107006856A (en) | One kind enhancing endurance, raising anti anoxia tolerance nutritional agents and preparation method thereof | |
KR100661132B1 (en) | Composition for curing a hangover and preparation method thereof | |
KR101293645B1 (en) | Phamaceutical composition for prevention or treatment of nephritis | |
CN115414458B (en) | A Chinese medicinal composition for treating hepatitis B, and its preparation method | |
CN104524214B (en) | Treat the Chinese medicine composition and its Chinese medicine preparation, preparation method and application of digestive tract ulcer | |
CN101112236B (en) | Health products having a hypoxia-tolerance function | |
KR100392876B1 (en) | A drink for eliminating a hangover and a method for producing the same | |
KR20090087671A (en) | Development of hypertension control beverage which from eucommia ulmoides | |
CN111135235A (en) | A composition for preventing and relieving acute alcoholism or alcoholic intoxication | |
KR100512912B1 (en) | Alcohol metabolism herbal medicine accelerator | |
KR100573245B1 (en) | Composition for relieving hangover and improving liver function | |
RU2393721C2 (en) | Agent and alcohol-free drink for prophylactics of consequences and reduction of manifestations of acute alcohol intoxication | |
CN101143203B (en) | Compound oral liquid with liver-protecting and stomach-nourishing function | |
KR0160402B1 (en) | Composition for prevention of stress |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |